vaginal birth after cesarean delivery

53
Candidate : Dr Nandini Jahagirdar Guide : Prof Neerja Bhatla Senior resident guide : Dr Praveen Kumar Vaginal Birth After Cesarean delivery (VBAC)

Upload: nandini-jahagirdar-joshi

Post on 12-Apr-2017

1.493 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Candidate : Dr Nandini JahagirdarGuide : Prof Neerja BhatlaSenior resident guide : Dr Praveen Kumar

Vaginal Birth After Cesarean delivery

(VBAC)

Cragin’s dictum,1916 “once a cesarean, always a cesarean”

In 1910, Mason and Williams – The strength of healed cesarean section scars

of guinea pigs & cats tested by subjecting to increasing weights.

Rupture was noted in the muscle but not the scar in 100% cases.

Kerr’s low transverse uterine incision – 1921 – reduced maternal mortality from sepsis & hemorrhage

-Gave greater strength to healed incision site

Background

Cragin himself witnessed VBAC in a woman in whom he did the cesarean NY Med . 1916;104:1–3

Rethinking the Dictum : Case in 1930s gave an excellent review on VBAC showing 70% success rate in British population J Obstet Gynaecol Br Commonw. 1971;78:203–14

In U.S., till 1970, patients with previous cesarean were mostly delivered by elective repeat cesarean – leading to Five-fold increase in rate of cesarean deliveries

From 1980 onwards, reappraisal of the situation, careful selection of candidates for VBAC began

First guideline was formed by ACOG in 1999

Elective repeat cesarean Delivery (ERCD) – Also called ERCS (Elective Repeat Cesarean Section)

Trial of labor after cesarean (TOLAC) This can have 2 outcomes

Successful TOLAC – Vaginal Birth After Cesarean Delivery (60 to 80%)

Failed TOLAC - Emergency cesarean Delivery

Options for a patient with previous cesarean

The available data is limited by 3 important factors

No Prospective, Randomized trials of TOL V/S ERCD available so far

Adverse maternal or perinatal outcomes are rare & large study populations are necessary to observe a significant difference in outcomes

The woman’s choice to attempt a TOLAC is heavily influenced by her health-care provider & local resources - leading to selection bias in published reports

Determining The Mode of Delivery

-Review previous

medical records & operative

notes,-Assess risks &

benefits

Antenatal Assessment & Counselling Points to be discussed Special considerationsMake patient understand the maternal & perinatal risks & benefits of VBAC V/S ERCD

Assess patient’s attitude towards the rare but serious adverse outcomes

Presence of contraindications to VBAC

Any complicating obstetric factors-Placenta praevia-Fetal malpresentations -Cervical fibroid -Maternal medical disorders -Previous classical scar -Previous uterine rupture -Previous peri-operative complications if any -Unknown scar, etc.

Likelihood of a successful VBAC Mostly if previous vaginal birth/successful VBAC

Her plans for future pregnanciesPersonal preference & motivation to achieve vaginal birth or ERCD

Risks And Benefits

Maternal benefitsVBAC ERCD

72- 76% chance of success Able to plan the delivery on a known date

If successful, shorter hospital stay & convalescence

Lower risk of vaginal tears & no worsening of pelvic floor support & continence mechanisms

Increased likelihood of vaginal delivery in future pregnancies

Surgical sterilization can be done at the same timeLower risk of transfusion (1%) & endometritis (1.8%) as compared to failed TOLAC

Maternal risksVBAC ERCD10-15% chance of instrumental delivery & perineal tear requiring suturing

Increases likelihood of cesarean delivery in future pregnancy

Failed TOLAC increases maternal morbidity

Longer hospital stay & convalescence

0.5% of risk of uterine scar rupture – most dreaded complication

0.1- 2% chances of serious surgical complications like bladder injury

24-28% of chance of emergency cesarean delivery

Increased risk of surgical complications with each subsequent cesarean delivery due to adhesions, placenta praevia/accreta

Higher risk of blood transfusion(1.7%) & endometritis(2%)

No . Of CD Placenta praevia

1 1%2 1.7%3 2.3%>3 2.8%Any no. 1.2%

No. of CD AHRQ Publication No. 10-E003March 2010

Placenta accreta

1 0.3-0.6%( not significant)

2 or more 1.4%5 or more 6.74%

Neonatal benefitsVBAC ERCD

<1% risk of transient respiratory morbidity (<ERCD)

Avoids 0.1% risk of antepartum still birth since delivery is undertaken at the commencement of 39th week

Neonatal risksVBAC ERCD

0.1% risk of antepartum still birth beyond 39 wks while awaiting spontaneous labor

1-3% risk of transient respiratory morbidity

0.04% risk of delivery related perinatal death

0.08% of HIE (Hypoxic ischaemic encephalopathy) during labor

Largest & most comprehensive Study is conducted by Landon et al Done in women enrolled in NICHD Maternal-Fetal

Medicine Units Network, 1999-2002 In TOLAC group , n= ~18000 In ERCD group, n= ~16000 This study includes all women who had a prior

cesarean delivery & who had a singleton pregnancy at 20 weeks or more of gestation or whose infant had a birth weight of at least 500 g

Women undergoing Cesarean for other indications were excluded

Maternal & perinatal outcomes in VBAC V/S ERCD

Maternal complications

N Engl J Med 2004,351:2581

Complication Trial of labor ERCD Normal laborUterine rupture 0.7% 0 0.012%

Gradeil F et al,ur J Obstet Gynecol Reprod Biol. Aug 1994;

Uterine dehiscence

0.7% 0.5%

Hysterectomy 0.2% 0.3% 0.14% ACOG2002

Thromboembolic disease

0.04% 0.1%

Transfusion 1.7% 1%Endometritis 2.9% 1.8% 1-2% Parkland

Hospital

Maternal deaths 0.02% 0.04%Other adverse events(broad-ligament hematoma, cystotomy, bowel injury, and ureteral injury)

0.4% 0.3%

Maternal deaths in TOL were 3 in no. & were due to

1.Severe PIH with hepatic failure2.Sickle cell crisis with cardiac arrest3.PPH

None of them could be directly attributed to TOL

Hysterectomy in ERCD(47)-1.Atony(17) 2.Placenta accreta(12)3.Unexplained hemorrhage(5)4.Extension / laceration(2)5.Myoma (3) 6.cancer(5) 7.Others (3)

Maternal deaths in ERCD were 7 in no.

Two of them could be attributed to

cesarean (Hemorrhage &

Anesthesia complications)

N Engl J Med 2004; 351:2581–9.

VBAC Failed TOLAC

Uterine rupture 0.1% 2.3%

Uterine dehiscence 0.1% 2.1%

Hysterectomy 0.1% 0.5%

Transfusions 1.2% 3.2%

Endometritis 1.2% 7.7%

Thromboembolic diseases

0.1% 0.02%

Maternal death 0.01% 0.04%

Other maternal adverse events

0.01% 1.3%

Maternal complications

Perinatal outcomes for term infantsOutcome TOL ERCDAntepartumstillbirth

37-38 wk 0.4% 0.1%39 wk or more 0.2% 0.1%Intrapartum stillbirth37-38wk 0.02% 039wk or more 0.01% 0HIE 0.08 0Neonatal death 0.08% 0.05%

N Engl J Med 2004; 351:2581–9.

Selection of candidates for VBAC

Previous 1 LSCS Clinically adequate pelvis No other uterine scar / previous rupture Physician immediately available throughout

active labor, capable of monitoring labor, performing an emergency cesarean delivery

Availability of anesthesia & personnel for emergency cesarean delivery

ACOG practice bulletin 2010

Special circumstances

VBAC success rate - 75.3% (in 2 or > previous LSCS) Uterine Rupture rate – 1.7% Miller et al.

(1994) In a meta-analysis, VBAC success rate – 71.1% ( Previous 2 LSCS ) Uterine rupture rate – 1.4% S Tahseen, M Griffiths -BJOG

2010;117:5–19.

No conclusive evidence available on methods of induction or augmentation of labor

More than one previous LSCS

Comparison of outcome of trial of labor after previous two Caesarean sections V/S previous one Cesarean sections – A Prospective clinical Trial is undergoing

at AIIMS by Dr Prerna under guidance of Prof Neerja Bhatla So far, 2 women with previous 2 LSCS have

had successful Trial of labor Both of them were induced with PGE2

(0.5mg) at 39-40wks

Several studies support VBAC in Twins with a success rate 69-84%

Rate of uterine rupture was not found significantly high - Miller et al and Strong et al

ACOG 2010 - “Women with one previous cesarean delivery with a low transverse incision, who are otherwise appropriate candidates for twin vaginal delivery, may be considered candidates for TOLAC”

Multiple pregnancy

“ERCD is associated with better perinatal outcome in a previous LSCS with Breech presentation in current pregnancy”

-A large multicentric trial by Hannah et al.-

External Cephalic Version (ECV) is not contraindicated – ACOG 2010 Flamm BL, Am JObstet Gynecol

1991;165:370–2, Sela HY, Eur J Obstet Gynecol Reprod Biol

2009;142:111–4

SOGC (Society of obstetricians & gynaecologists of Canada) discourages VBAC in Breech

Breech presentation

Suspected macrosomia (>4000g) is not a contraindication for TOL but decreases success rate of VBAC -Elkousy et al(2003)

Success rate of 60% is observed -Zelop et al. Am J Obstet

Gynecol 185:903, 2001

Macrosomia

No significant difference in the outcome of the next pregnancy

Chapman et al, Ohel et al, Hauth et al

Few studies although found increased risk of uterine rupture, no sufficient data available

Durwald & Mercier, Bujold et al Longterm outcomes of CORONIS Trial (A large

randomised multicentre fractional, factorial trial) & CAESAR Trial (Caesarean section surgical techniques: a

randomised factorial trial) are awaited

Single v/s Double layer closure of Uterus

Other Factors

Maternal obesity – Decreases probability of VBAC - BMI >40 associated with 61% chances of successful VBAC Hibbard et al, Juhas et al

History of postpartum fever after Caesarean section - 3 fold increase in rupture Shipp T et al Am J Obstet

Gynecol.2001;184:S71

Mullerian duct anomalies – 8% risk of rupture

Ravasia et al, Am J ObstetGynecol. 1999;181:877–881

Maternal age - <30yrs (Decrease risk of uterine rupture : 0.5% v/s 1.4%)

Shipp T et al Am J Obstet

Gynecol.2001;184:S71.-Their relationship to the risk of uterine rupture have been examined in

small studies, but definitive conclusions cannot yet be drawn.

Related to Previous Cesarean Delivery

Previous classical or T /J shaped uterine incision Previous uterine rupture Uterine surgeries involving full muscle thickness (Hysterotomy, Preterm LSCS, myomectomy with cavity

opened. No consistent evidence available for incidence of uterine

rupture in Laparoscopic v/s open myomectomy) Previous >2 LSCS (VBAC in previous 3 LSCS has been reported as early as in1979 but not enough evidence

available) Unknown scar – In the absence of previous operative

records, a detailed history may be taken Most common incision, however is, low transeverse & VBAC

is reasonable Obstet Gynecol.1994;84:255–258

Contraindication to trial of labor after cesarean (TOLAC)

Obstetric or Medical complication

Malpresentation Antepartum hemorrhage- Placenta praevia, Placenta

accreta Severe PIH/eclampsia Placental insufficiency (IUGR, Oligohydramnios) Medical disorders like HTN, Heart disease, Renal disease,

Asthma, Seizure disorders, Thyroid disorders (Grobmann et al – Inconsistent evidence, VBAC can be

given)

Contracted pelvis/CPD

Inability to perform emergency cesarean due to insufficient staffing / facilities

Predicting the success v/s failure

of Trial of Labor

ACOG practice bulletin 2010

Increased probability of success of TOLACPrior vaginal birthSpontaneous onset of Labor

Decreased probability of successRecurrent indication for initial cesarean delivery ( Dystocia, CPD)Increased maternal AgeNonwhite ethnicityGestational age > 40 weeksMaternal obesityPre-eclampsiaShort interpregnancy intervalIncreased neonatal birth weight

Factors increasing likelihood of successMaternal age < 40Prior vaginal deliveryFavorable cervix, spontaneous laborPrior cesarean for non recurrent indication

Factors decreasing likelihood of success Increased no of prior cesarean deliveriesGestational age > 40 weeksBirth weight > 4 kg Induction or augmentation of labor

Criteria for success (American academy of family physicians)

Factors decreasing risk of failure Age <40 Prior vaginal delivery Indication for previous cesarean other than failure

of progress Cervical effacement at admission > 75% Cervical dilatation at admission > 4cm

Score 0-2 has success rate of 49% & for 8-10, 95% Flamm ,Obstet gynecol 1994;83:927-32

Scoring system to predict Success v/s Failure of VBAC

Grobman & colleagues (2007) Developed a nomogram to predict a

successful TOL & maternal morbidity based on a questionnaire in a term gestation with previous 1 LSCS

-A score >60 has a 75-80% chances of a successful vaginal delivery

Obstetrics and Gynecology, volume 109, pages 806-12, 2007

E-Calculator

http://www.nialls.com/VBACPred2.aspx

Defined as “A primary cesarean delivery at maternal request in the absence of any medical or obstetrical indication”.

(ACOG–American College of Obstetrician and Gynecologists, Committee Opinion, Number 394, December 2007)

Cesarean Delivery by Maternal Request (CDMR)

-ACOG states Elective cesareans are justified options

-FIGO(2003) entails CDMR ‘a positive right of women’

Lower incidence of endometritis/ transfusions Lower Neonatal / Perinatal Morbidity Fewer Infant Birth Injuries during Delivery Better Maternal Postpartum Satisfaction &

Psychological Wellbeing Better Sexual Health in the Immediate

Postpartum Period & in some cases, long term Reduced or Avoided Urinary Incontinence & Fecal

Incontinence Less damage to pelvic floor, vaginal tearing,

episiotomy, and risk of future pelvic organ prolapse

Factors influencing CDMR

Intrapartum management

Take detailed informed written consent

To be conducted in a suitably staffed & equipped setting with the facility for emergency cesarean delivery 24x7 & neonatal resuscitation

An Obstetrician, Anesthesiologist & pediatrician should be immediately available

PGE 2 may be used to induce labor with caution.

IV access, adequate blood cross matched

Monitor maternal BP, PR & ST every 15 min

Intrapartum management

Continuous fetal monitoring by CTG (II A)

Intrauterine pressure catheters - not routinely useful

Oxytocin should be used with caution (In AIIMS - low dose, starting from 1mIU/min is being used for augmentation)

No contraindication for epidural analgesia – does not reduce success or mask signs of rupture

Regular review of partogram by senior obstetrician

Routine postpartum exploration of scar - not needed

Most Dreaded complication of TOLAC

Relative risk of uterine rupture in TOL compared to ERCD is 2.07

Maternal and or fetal morbidity of rupture 10-25%

In rupture, 1.5/10,000 risk of perinatal death &

4.8/10,000 risk of hysterectomy

Uterine rupture

Uterine rupture – Complete disruption of all layers of uterus associated with one/more of the following-

Hemorrhage requiring surgical exploration Hysterectomy, Injury to the bladder Extrusion of any part of feto-placental unit Cesarean delivery for suspected uterine rupture Cesarean delivery for fetal distress

Uterine dehiscence – Asymptomatic uterine disruption (complete or incomplete) having no effect on mother or neonate

Uterine rupture V/S Uterine dehiscence

Most Reliable First sign is - “Non reassuring fetal heart tracing”

Most Specific sign is - Persistent variable fetal heart deceleration.

Clinical signs of uterine rupture

Classical signs (Unreliable) Maternal tachycardia, Hypotension, Hematuria, Pain over previous incision site Vaginal bleeding

Dramatic loss of station Low sensitivity, high specificity

Clinical signs of Uterine Rupture….

Risk factors for uterine rupture

Factors known at the outset of pregnancy

Factors Rate of uterine ruptureType of scarClassical 12% ( Rosen et al ) Low transverse (Kerr) 1% (Mc Mohan et al)

Low vertical (Kronig) 0.8%-1.1% (N Engl J Med 2001;345:3–8) (Adair et al, Shipp et al)

Myomectomy scar with cavity open or transfundal surgeries

10%

Number of Previous LSCS BJOG 2010;117:5–19

1 LSCS 0.8%2 LSCS 1.4%

Factors Rate of Uterine Rupture

Interdelivery interval Shipp T et al Am J Obstet Gynecol.2001;184:S71<18 months 2.3%>18 months 1%Previous vaginal delivery Zelop et al

Prev 1 LSCS v/s Prev 1LSCS+ vaginal birth

1.1% v/s 0.2%

Prev 2 LSCS v/s Prev 2 LSCS + vaginal birth

3.9% V/S 2.5% ( statistically not significant)

Previous h/o ruptureLower segment 6%Upper segment 32%

Factors known at the outset of pregnancy

Current pregnancy characteristicsFactors Rate of Uterine RuptureMacrosomia (>4kg) 1.6% v/s 1% (statistically not

significant) (Obs Gynecol 2003;188(6):516)

Postdatism v/s Term deliveries (Obs Gynecol 2005;(106):700-8)

Spontaneous 1% v /s 0.5% (Statistically not significant)

Induced 2.6% v/s 2.1% (statistically not significant)

Preterm Lower rates

Twin pregnancy Similar rates, but 2 fold increased risk of dehiscence

Breech & ECV Results not definitive

Rozenberq P et al , Lancet :1996 ;347(8997):281-4

Lower uterine segment thickness

Number of cases

Number of ruptures

> 4.5 mm 278 0

3.6 – 4.5 mm 177 3 (2%)

2.6 – 3.5 mm 136 14 (10%)

1.6 – 2.5 mm 51 8 (16%)

Current pregnancy characteristics

Induction and augmentation of labor in VBAC and Uterine ruptureFactors Rate of Uterine Rupture

( v/s Spontaneous Labor )Oxytocin Induction 2.3% v/s 0.7% Augmentation 1% v/s 0.4% ( comparable)

ACOG Committee opinion no:271, apr 2002

Prostaglandin E2 1.3% v/s 0.7% ( comparable)Prostaglandin E1 5.6%Intracervical foley’ catheter Safe

Also recommended in second trimester induction

Mifepristone Under evaluation

Exposure to oxytocin before the active stage of labor may increase risk of ruptureNo co-relation with initial dose, maximal dose, dose titration, time at maximum doseGoetzl et al, Obs Gynecol 2001; 97(3):384

Cost of failed TOLAC is more than successful TOL or repeat cesarean

If rupture rate > 3.2%, the increased infant morbidity/mortality of attempted TOLAC exceeded the benefits of reduced cost

TOLAC is cost effective if the rate of successful vaginal delivery >74%

So careful patient selection is necessary before planning TOL

Obs Gynecol 2001;97:932-41

Economics of VBAC

ACOG practice bulletin 2010

Most women with previous 1 LSCS are candidates for VBAC & Should be counseled about VBAC & offered TOLAC

Epidural analgesia for labor may be used as part of TOLAC

Misoprostol should not be used for 3rd trimester cervical ripening or labor induction in patients with previous cesarean delivery or major uterine surgeries

ACOG Guidelines Level A Evidence

VBAC is recommended in previous 2 LSCS with low transverse scar and previous 1 LSCS with twins

ECV for breech is not contraindicated in previous LSCS Scars other than low transverse/ low vertical scars or those

in whom Vaginal delivery is contraindicated (eg.placenta accreta) are contraindications for VBAC

Induction of labor for maternal/fetal indication remains an option

Previous unknown uterine scar is not a contraindication unless there is high suspicion of classical cesarean delivery

Level B evidence

ACOG practice bulletin 2010

There are no areas of significant difference as compared to RCOG

Guidelines -2007 -RCOG also encourages trial in 3

or more previous cesarean deliveries

THANK YOU